NIH Issues Program Announcements for Bioinformatics SBIR Awards
The National Institutes of Health last week issued two program announcements describing its Small Business Innovation Research and Small Business Technology Transfer award programs for bioinformatics grants.
The program announcements, both titled "Innovations in Biomedical Computational Science and Technology," are available at http://grants.nih.gov/grants/guide/pa-files/PAR-06-088.html and http://grants.nih.gov/grants/guide/pa-files/PAR-06-089.html.
The NIH did not provide exact funding amounts that it plans to award under the programs.
Specific research areas solicited under the programs include: the development of tools for data acquisition, archiving, querying, retrieval, visualization, integration, and management; the development of platform-independent translational tools for data exchange and for promoting interoperability; web-based linkage tools for data sharing and tools for electronic communication; new analytical and statistical tools for interpretation of large and complex data sets; and new models or simulations of complex biological processes and systems.
Applications for both programs are due on Feb. 26.
Undisclosed Top-Three Pharma Renews License for Simulations Plus Software
Simulations Plus said last week that it has received a purchase order from "a top three pharmaceutical company" for the renewal of a global license for users at six sites in the US, Europe, and Japan.
Ron Creeley, vice president of marketing and sales of Simulations Plus, said in a statement that the value of the deal is "hundreds of thousands of dollars."
The order covers the company's GastroPlus software and extension modules, including the PBPKPlus Module.
IBM, Adobe Among First Six Vendors to Join SAFE-BioPharma Electronic Signature Initiative
Six technology companies will develop software and applications for the pharmaceutical and healthcare industries using a digital signature standard developed by the SAFE-BioPharma Association, the organization said last week.
The SAFE (Secure Access for Everyone) Vendor Partner Program encourages development of business applications, infrastructure, services and identity credentials, the association said. SAFE-BioPharma will test each application to guarantee it conforms to SAFE requirements.
Adobe, Arcot Systems, CoreStreet, nCipher, IBM, and Kyberpass are the first members of the program.
SAFE is expected to reduce medical research and drug development costs. The National Cancer Institute, US Food and Drug Administration, and the European Medicines Agency have committed to adopting the SAFE standard.
(See BioInform's interview with Guy Tallent, program director for the SAFE-BioPharma Association, for more information about the organization's activities [BioInform 06-27-05])
Eidogen-Sertanty Licenses Software to Cephalon
Eidogen-Sertanty said this week that Cephalon has licensed its Kinase Knowledgebase, Target Informatics Platform, and EVE comparative visualization software.
Cephalon researchers will use the software to support small-molecule drug discovery projects in the company's neurology and oncology therapeutic programs, Eidogen-Sertanty said.
Financial terms of the agreement were not disclosed.
Northern Kentucky Chamber of Commerce Seeks $34M for Informatics Center at NKU
The Northern Kentucky Chamber of Commerce is lobbying for up to $33.9 million to fund a Center for Informatics at Northern Kentucky University, according to the NKCC website.
The funding request is one of several "priority project needs" recently identified by the NKCC.
According to the NKCC, an informatics center would "bring together multiple departments to create an integrated College of Informatics, which will focus on developing new uses for information technology in order to solve specific problems in areas ... [including] biology."